Literature DB >> 26227960

T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.

Gloria Kim1, Fariha Khalid2, Vinit V Oommen3, Shahamat Tauhid4, Renxin Chu5, Mark A Horsfield6, Brian C Healy7, Rohit Bakshi8,9,10.   

Abstract

BACKGROUND: The reliable and efficient measurement of spinal cord atrophy is of growing interest in monitoring disease progression in multiple sclerosis (MS).
METHODS: We compared T1- and T2-weighted MRI for measuring cervical spinal cord volume in 31 patients with MS and 18 age-matched controls (NC) from T1-weighted gradient recalled echo and T2-weighted fast spin-echo 1.5 T axial acquisitions. The two sequences were matched on slice thickness, signal averages and voxel size. An active surface software tool determined the normalized mean cervical cord cross-sectional area.
RESULTS: T1-derived cord areas were higher than T2 areas in the whole cohort (estimated mean difference = 7.03 mm(2) (8.89%); 95% Confidence Interval (CI): 5.91, 8.14; p < 0.0001) and in both groups separately. There were trends for lower spinal cord areas in MS vs. NC with both sequences. For the T1 cord area, the mean difference was 3.7 mm(2) (4.55%) (95% CI: -1.36, 8.78; p = 0.15). For the T2 cord area, the difference was larger [mean difference 4.9 mm(2) (6.52%) (95% CI: -0.83, 10.67); p = 0.091]. The T1 and T2 cord areas showed similar weak to moderate correlations with measures of clinical status and T2 spinal cord lesion volume in the MS group. Superficial spinal cord T2 lesions had no apparent confounding effect on the outlining tool. The mean intra-rater and inter-rater coefficients of variation ranged from 0.27 to 0.91% for T1- and 0.66 to 0.99% for T2-derived cord areas.
CONCLUSION: T2-weighted images may prove efficient for measuring cervical spinal cord atrophy in MS, with the added advantage of lesion detectability.

Entities:  

Mesh:

Year:  2015        PMID: 26227960      PMCID: PMC4521382          DOI: 10.1186/s12883-015-0387-0

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


Background

Brain and spinal cord lesions and atrophy are key MRI findings in the evaluation of patients with multiple sclerosis (MS). Many MRI segmentation methods have been developed to quantify spinal cord atrophy, including manual, semi-automated, and fully automated segmentation algorithms [1-10]. Manual outlining of axially acquired spinal cord images was initially used to monitor cord atrophy [6]. However, this lacked efficiency and precision. The use of edge-finding tools led to higher reproducibility by reducing user interactions [6-8]. In the past few years, the level of automation has increased in cord contouring algorithms. The active surface method [2] simply requires that the user marks the center of the cord on several vertebral levels of interest. This allows a rapid semi-automated segmentation by measuring the cord cross-sectional areas along the length of the extracted surface parameter [2]. Most recently, fully automated spinal cord segmentation methods have also been developed to produce reliable and accurate cord contouring [1, 10]. Spinal cord atrophy is most relevant to progressive forms of MS, i.e. primary progressive (PP) and secondary progressive (SP), in which it closely links to physical disability [2-6]. In most research settings, T1-weighted gradient recalled sequences are used to measure spinal cord volume. However, T2-weighted spin-echo sequences are more routinely used in MS clinics to assess lesions in addition to their potential role in measuring spinal cord volume. We compared two commonly-available sequences to measure cord volume: 1) T2-weighted fast spin-echo (FSE) sequences; 2) T1-weighted gradient recalled echo (GRE) sequences.

Methods

Subjects’ characteristics are listed in Table 1. In the MS group, disability was assessed by the Expanded Disability Status Scale (EDSS) and timed 25-foot walk. Subjects underwent cervical spinal cord MRI on the same Philips 1.5 T scanner. For both sequences, axial images were obtained with a voxel size of 0.898 × 0.898 × 3 mm (no interslice gaps) with the same inferior-superior coverage and 2 signal averages. One hundred fifty to 200 axial slices were acquired on each subject to cover the whole spinal cord from the foramen magnum to the inferior extent of the conus medullaris. For the purposes of this study, only slices extending from the superior aspect of the C1 vertebral body to the inferior aspect of C7 were analyzed. The repetition (TR) and echo (TE) times (in milliseconds) [mean (range)] were, for the GRE sequence, TR = 520 (439–612) and TE = 4.26 (4.24-4.34). For the FSE sequence, TR = 9436 (8822–10659); TE = 100 in all subjects. All subjects gave informed consent for this study, which was approved by the local ethics committee of Partners Health Care. This human research was in compliance with the Helsinki Declaration (http://www.wma.net/en/30publications/10policies/b3/index.html).
Table 1

Subject characteristics

Multiple sclerosisNormal controls
Number N = 31 N = 18
Age (years) (mean ± SD)43.3 ± 8.743.6 ± 8.1
Women, number (%)21 (68 %)14 (78 %)
Disease category, number (%)
 Relapsing-remitting26 (84 %)-
 Secondary progressive4 (13 %)-
 Primary progressive1 (3 %)-
Disease durationa (years) (mean ± SD)9.0 ± 8.3-
Expanded Disability Status Scale score (mean ± SD)2.1 ± 2.1-
Timed 25-foot walk (mean ± SD)6.0 ± 5.2-
T1 normalized cord area (mm2) (mean ± SD)77.7 ± 10.681.4 ± 7.0
T2 normalized cord area (mm2) (mean ± SD)70.2 ± 10.575.1 ± 9.0

SD standard deviation

atime since first symptoms

Subject characteristics SD standard deviation atime since first symptoms Image analysis was performed by a validated active surface method [2] using the Jim software package (v. 6.0 Xinapse Systems, West Bergholt, UK; www.xinapse.com). The whole cervical cord (C1 to C7) was measured (Fig. 1 shows sample images and segmentations). Spinal cord volume was normalized by dividing the total volume by the number of axial slices [3]. The operator analysis time per scan was the same for the T1 or T2 scans (~20 min). All MRI analysis was performed in a blinded manner, without knowledge of clinical details. To collect data on intra-rater and inter-rater reliability, five randomly chosen subjects (3 MS patients and 2 normal controls - NC) were analyzed. Two operators performed data analysis independently, with one rater analyzing the data a second time to assess intra-rater reliability.
Fig. 1

T1-weighted gradient echo (a–d) and T2-weighted fast spin-echo (e–h) axial MRI scans from C2. Left = raw images; right = cord outlines (red) after segmentation. a, b, e, f: Patient with relapsing-remitting MS [41 year-old woman, 5.4 years disease duration, low physical disability (EDSS score = 1)]. c, d, g, h: Normal control (49 year-old woman)

T1-weighted gradient echo (a–d) and T2-weighted fast spin-echo (e–h) axial MRI scans from C2. Left = raw images; right = cord outlines (red) after segmentation. a, b, e, f: Patient with relapsing-remitting MS [41 year-old woman, 5.4 years disease duration, low physical disability (EDSS score = 1)]. c, d, g, h: Normal control (49 year-old woman) In addition, the presence of T2 hyperintense lesions in the cervical spinal cord was analyzed in all subjects to determine whether spinal cord lesions affected the cord contouring tool (Table 2, Fig. 2). The total volume and total number of cervical spinal cord T2 lesions were assessed. The number of lesions adjacent to the outer surface of the cord and the number of T2 lesions causing errors in the cord contour algorithm were also assessed. To confirm whether lesions in contact with the outer surface of the spinal cord interfered with cord segmentation, both the segmented cord outline and lesion tracings were overlaid using Jim software.
Table 2

T2 hyperintense cervical spinal cord lesions in the MS group

Patient #Total cervical lesion volume (mm3)Total # of cervical lesions# of lesions contacting outer spinal cord surface# of lesions causing contouring error
100--
243.510-
300--
466.410-
500--
6161.820-
700--
867.220-
9337.8430
1050.510-
1100--
12181.820-
1300--
14164.610-
1553.810-
16782.3520
1700--
18553.3420
19394.0410
20104.830-
2100--
2200--
2300--
24293.3410
25285.850-
2628.410-
2700--
28110.930-
29163.940-
3000--
31754.7110
Mean148.41.60.50
SD215.71.70.90
Range0–782.30–50–30-0
Fig. 2

Performance of the cord-contouring tool with the presence of T2 hyperintense spinal cord lesions. Spinal cord lesion (green) and cord outline after segmentation (red). a: Axial slice at C2 from a patient with relapsing-remitting MS (52 year-old man, disease duration = 15.8 years, Expanded Disability Status Scale score [EDSS] = 1); b: Axial slice at C5 from a patient with relapsing-remitting MS (47 year-old man, disease duration = 12.4 years, EDSS = 0)

T2 hyperintense cervical spinal cord lesions in the MS group Performance of the cord-contouring tool with the presence of T2 hyperintense spinal cord lesions. Spinal cord lesion (green) and cord outline after segmentation (red). a: Axial slice at C2 from a patient with relapsing-remitting MS (52 year-old man, disease duration = 15.8 years, Expanded Disability Status Scale score [EDSS] = 1); b: Axial slice at C5 from a patient with relapsing-remitting MS (47 year-old man, disease duration = 12.4 years, EDSS = 0) To assess agreement between T1 and T2 normalized cord areas, their within-subject differences were calculated and a paired t-test assessed significance. A Bland-Altman plot of the average normalized cord area vs. the difference between the two measures depicted the agreement between the two scans. Student’s t-tests compared groups. Spearman’s rank or Pearson’s correlations linked MRI to MRI, age or clinical measures. A p <0.05 was considered significant.

Results

Considering all subjects, the T1 cord areas were higher than the T2 areas [estimated mean difference = 7.03 mm2; 95 % Confidence Interval (CI): 5.91, 8.14; p < 0.0001, Table 1, Fig. 3]. This represented an 8.89 % difference [(mean difference/mean T1 cord area) × 100 %] between the mean T1 and T2 cord areas. This was consistent across all subjects (with only one NC having a higher T2 than T1 normalized cord area) and persisted when analyzing the two groups separately [estimated mean difference in MS = 7.47 mm2 (9.61 %); 95 % CI: 6.29, 8.65, p < 0.0001; NC = 6.26 mm2 (7.69 %); 95 % CI: 3.86, 8.67; p < 0.0001].
Fig. 3

Bland-Altman plot showing all subjects – units of measure = mm2. T1 normalized cord areas are higher than T2 areas (estimated mean difference = 7.03 mm2; 95 % CI: 5.91, 8.14; p < 0.0001). Only one subject had a higher T2 normalized cord area than T1

Bland-Altman plot showing all subjects – units of measure = mm2. T1 normalized cord areas are higher than T2 areas (estimated mean difference = 7.03 mm2; 95 % CI: 5.91, 8.14; p < 0.0001). Only one subject had a higher T2 normalized cord area than T1 Data regarding the presence of spinal cord lesions on T2-weighted images are shown in Table 2 and Fig. 2. No lesions were present in the NC group. Among the 31 MS patients, 19 (61 %) had at least one spinal cord lesion. Six of these patients had lesions in contact with the outer spinal cord surface, none of which caused visually-apparent errors in the cord contouring algorithm (Fig. 2). There were trends for lower spinal cord areas in the MS vs. NC groups when measured from the T1- or T2-weighted images (Table 1). For the T1 cord area, the mean difference was 3.7 mm2 (4.55 %) (95 % CI: −1.36, 8.78; p = 0.15). For the T2 cord area, the difference was larger, with MS showing greater atrophy, but this again did not reach significance [mean difference 4.9 mm2 (6.52 %) (95 % CI: −0.83, 10.67); p = 0.091]. The percent differences between MS and NC groups were calculated as the (mean difference/mean NC area) × 100 %. The T1 and T2 cord areas showed similar weak to moderate correlations with three measures of clinical status in the MS group (Table 3). Spinal cord area vs. EDSS was similarly significant with both T1 (p = 0.032) and T2 (p = 0.033) cord measures (Table 3). Similarly, both T1 (p = 0.04) and T2 (p = 0.07) cord area measures showed approximately the same degree of negative association with the total volume of cervical spinal cord T2 lesions (Table 3).
Table 3

Correlation between spinal cord area and other variables in the MS group (n = 31)

T1 normalized cord areaT2 normalized cord area
rs p-valuers p-value
Age−0.1600.380−0.2000.290
Disease durationa −0.2490.177−0.2480.178
Expanded Disability Status Scale score−0.3860.032−0.3830.033
Timed 25-foot walk−0.2810.126−0.2600.157
Total cervical volume of spinal cord T2 lesions−0.3700.040−0.3300.070

r Spearman coefficient

ayears since first symptoms

Correlation between spinal cord area and other variables in the MS group (n = 31) r Spearman coefficient ayears since first symptoms Across all subjects, there were no correlations between age and T1 areas (r = −0.002, p = 0.99) or T2 areas (r = −0.001, p = 0.995). The MS group data are shown in Table 3. Considering just the NC group, there was a trend to correlation between age and T1 areas (r = 0.453, p = 0.059) and T2 areas (r = 0.419, p = 0.083); the interpretation of these trends was hampered by the small sample size in the NC group. The method was highly reproducible, with mean coefficients of variation (COVs) of 0.27 % (intra-rater) and 0.91 % (inter-rater) for normalized cord area measured from T1 sequences and 0.66 % (intra-rater) and 0.99 % (inter-rater) from T2 sequences.

Discussion

Despite differences in the volumes obtained, the two axial T1-weighted and T2-weighted sequences showed similar validity and reliability in the assessment of cervical spinal cord volume in MS. Regarding validity, the two measures showed similar differences between MS and NC and similar correlations with clinical measures in the MS group. Considering reliability, the intra-rater COV for each was acceptable. A variety of acquisitions, including T1- and T2-weighted images can detect a relationship between spinal cord volume and MS disability [2, 5–10]. Spinal cord imaging is routine in MS care and provides unique and complementary information on disease severity that is not captured by brain MRI [8, 11, 12]. However, the “gold standard” images used to measure spinal cord volume in research settings (e.g. 3D T1-weighted, 1 mm isotropic voxels) are not typically feasible in routine care due to costs, scan time restrictions, and their questionable clinical applicability. Thus, clinically routine spinal cord images are more practical for large-scale MS studies. The T2-weighted FSE images have the added advantage of detecting inflammatory/demyelinating spinal cord lesions. Our results extend previous work [1, 2] and suggest that such images may provide a stand-alone tool to efficiently measure cervical spinal cord volume in MS. In the present study, we showed no confounding effect of superficially placed T2 hyperintense spinal cord lesions on the accuracy of the cord contouring tool. However, it is important to note that we may not have seen an effect due to the fact that most of our MS patients were relapsing-remitting and the presence of spinal cord lesions was not ubiquitous. Future studies with larger sample sizes of progressive cases would be necessary to fully evaluate the potential confounding effect of lesions on the cord outline on T2-weighted images. Such progressive cohorts with more advanced disease will be required to fully evaluate the differences between MS and NC, which were not detected in our sample of mostly mildly disabled patients. While T2-weighted images showed high intra- and inter-rater reliability, the scan-rescan reliability remains to be determined. Longitudinal studies will uncover the sensitivity of T2-weighted images for monitoring spinal cord volume change and treatment effects. Further studies should also assess the role of 3D high-resolution scan acquisitions.

Conclusion

T2-weighted images may prove efficient for measuring cervical spinal cord atrophy in MS, showing comparable effect sizes to T1-weighted images with the added advantage of lesion detectability.
  12 in total

1.  A multicenter assessment of cervical cord atrophy among MS clinical phenotypes.

Authors:  M A Rocca; M A Horsfield; S Sala; M Copetti; P Valsasina; S Mesaros; V Martinelli; D Caputo; T Stosic-Opincal; J Drulovic; G Comi; M Filippi
Journal:  Neurology       Date:  2011-06-14       Impact factor: 9.910

2.  Robust, accurate and fast automatic segmentation of the spinal cord.

Authors:  Benjamin De Leener; Samuel Kadoury; Julien Cohen-Adad
Journal:  Neuroimage       Date:  2014-04-27       Impact factor: 6.556

3.  The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.

Authors:  Adam B Cohen; Mohit Neema; Ashish Arora; Elisa Dell'oglio; Ralph H B Benedict; Shahamat Tauhid; Daniel Goldberg-Zimring; Christian Chavarro-Nieto; Antonella Ceccarelli; Joshua P Klein; James M Stankiewicz; Maria K Houtchens; Guy J Buckle; David C Alsop; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-03-29       Impact factor: 2.486

4.  Approaches to normalization of spinal cord volume: application to multiple sclerosis.

Authors:  Brian C Healy; Ashish Arora; Douglas L Hayden; Antonia Ceccarelli; Shahamat S Tauhid; Mohit Neema; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-08-19       Impact factor: 2.486

5.  Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis.

Authors:  Mark A Horsfield; Stefania Sala; Mohit Neema; Martina Absinta; Anshika Bakshi; Maria Pia Sormani; Maria A Rocca; Rohit Bakshi; Massimo Filippi
Journal:  Neuroimage       Date:  2010-01-07       Impact factor: 6.556

6.  Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis.

Authors:  R Zivadinov; A C Banas; V Yella; N Abdelrahman; B Weinstock-Guttman; M G Dwyer
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

7.  Spinal cord normalization in multiple sclerosis.

Authors:  Jiwon Oh; Michaela Seigo; Shiv Saidha; Elias Sotirchos; Kathy Zackowski; Min Chen; Jerry Prince; Marie Diener-West; Peter A Calabresi; Daniel S Reich
Journal:  J Neuroimaging       Date:  2014-03-05       Impact factor: 2.486

8.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

9.  Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images.

Authors:  Simon J Hickman; Olivier Coulon; Geoffrey J M Parker; Gareth J Barker; Valerie L Stevenson; Declan T Chard; Simon R Arridge; Alan J Thompson; David H Miller
Journal:  J Magn Reson Imaging       Date:  2003-09       Impact factor: 4.813

10.  An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.

Authors:  Rohit Bakshi; Mohit Neema; Shahamat Tauhid; Brian C Healy; Bonnie I Glanz; Gloria Kim; Jennifer Miller; Julia L Berkowitz; Riley Bove; Maria K Houtchens; Christopher Severson; James M Stankiewicz; Lynn Stazzone; Tanuja Chitnis; Charles R G Guttmann; Howard L Weiner; Antonia Ceccarelli
Journal:  Neuroreport       Date:  2014-10-01       Impact factor: 1.837

View more
  6 in total

1.  Evaluation of a Workflow to Define Low Specific Absorption Rate MRI Protocols for Patients With Active Implantable Medical Devices.

Authors:  Jessica A Martinez; Kévin Moulin; Bryan Yoo; Yu Shi; Hyun J Kim; Pablo J Villablanca; Daniel B Ennis
Journal:  J Magn Reson Imaging       Date:  2020-01-10       Impact factor: 4.813

2.  Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.

Authors:  Subhash Tummala; Tarun Singhal; Vinit V Oommen; Gloria Kim; Fariha Khalid; Brian C Healy; Rohit Bakshi
Journal:  Int J MS Care       Date:  2017 May-Jun

3.  Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Authors:  Keren Regev; Brian C Healy; Fariha Khalid; Anu Paul; Renxin Chu; Shahamat Tauhid; Subhash Tummala; Camilo Diaz-Cruz; Radhika Raheja; Maria A Mazzola; Felipe von Glehn; Pia Kivisakk; Sheena L Dupuy; Gloria Kim; Tanuja Chitnis; Howard L Weiner; Roopali Gandhi; Rohit Bakshi
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

4.  The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis.

Authors:  Sheena L Dupuy; Fariha Khalid; Brian C Healy; Sonya Bakshi; Mohit Neema; Shahamat Tauhid; Rohit Bakshi
Journal:  BMC Med Imaging       Date:  2016-10-05       Impact factor: 1.930

5.  The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.

Authors:  Fawad Yousuf; Gloria Kim; Shahamat Tauhid; Bonnie I Glanz; Renxin Chu; Subhash Tummala; Brian C Healy; Rohit Bakshi
Journal:  Front Neurol       Date:  2016-06-29       Impact factor: 4.003

6.  The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.

Authors:  Tarun Singhal; Shahamat Tauhid; Shelley Hurwitz; Mohit Neema; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2016-07-28       Impact factor: 2.486

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.